The Impact of COVID-19 is included in Womens Health Diagnostic Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Womens Health Diagnostic Trends and Forecast
The future of the global womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets. The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Womens Health Diagnostic by Segment
The study includes a forecast for the global womens health diagnostic by end use industry, application, and region.
Womens Health Diagnostic Market by End Use Industry Industry [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals & Clinics
• Diagnostic & Imaging Centers
• Home Care Settings
• Others
Womens Health Diagnostic Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Osteoporosis Testing
• OVC Testing
• Cervical Cancer Testing
• Breast Cancer Testing
• Pregnancy & Fertility Testing
• Prenatal Genetic Screening & Carrier Testing
• Infectious Disease Testing
• STD Testing
• Ultrasound Tests
• Others
Womens Health Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Womens Health Diagnostic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies womens health diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the womens health diagnostic companies profiled in this report include-
• F. Hoffmann-La Roche
• Siemens Aktiengesellschaft
• Quest Diagnostics Incorporated
• GE Healthcare
• Koninklijke Philips
• General Motors
• Abbott Laboratories
• Becton
• Dickinson
• Hologic
Womens Health Diagnostic Market Insights
Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.
Within this market, home care settings will remain the largest segment due to increasing advantages of using self-testing kits.
North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.
Features of the Global Womens Health Diagnostic Market
Market Size Estimates: Womens health diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Womens health diagnostic market size by end use industry, application, and region in terms of value ($B).
Regional Analysis: Womens health diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different end use industry, application, and regions for the womens health diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the womens health diagnostic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the womens health diagnostic market size?
Answer: The global womens health diagnostic market is expected to reach an estimated $48.82 billion by 2030.
Q.2 What is the growth forecast for womens health diagnostic market?
Answer: The global womens health diagnostic market is expected to grow with a CAGR of 8.1% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the womens health diagnostic market?
Answer: The major drivers for this market are high prevalence of infectious diseases in women and growing adaption of POC dignostic testing.
Q4. What are the major segments for womens health diagnostic market?
Answer: The future of the womens health diagnostic market looks promising with opportunities in the hospitals & clinics, diagnostic and imaging centers, and home care settings markets.
Q5. Who are the key womens health diagnostic market companies?
Answer: Some of the key womens health diagnostic companies are as follows:
• F. Hoffmann-La Roche
• Siemens Aktiengesellschaft
• Quest Diagnostics Incorporated
• Ge Healthcare
• Koninklijke Philips
• General Motors
• Abbott Laboratories
• Becton
• Dickinson
• Hologic
Q6. Which womens health diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that breast cancer is expected to witness highest growth over the forecast period due to high occurrence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as abus.
Q7. In womens health diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of cancer among women.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the womens health diagnostic market by end use industry (hospitals & clinics, diagnostic & imaging centers, home care settings, and others), application (osteoporosis testing, ovc testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Womens Health Diagnostic Market, Womens Health Diagnostic Market Size, Womens Health Diagnostic Market Growth, Womens Health Diagnostic Market Analysis, Womens Health Diagnostic Market Report, Womens Health Diagnostic Market Share, Womens Health Diagnostic Market Trends, Womens Health Diagnostic Market Forecast, Womens Health Diagnostic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Womens Health Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Womens Health Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Womens Health Diagnostic Market by End Use Industry Industry
3.3.1: Hospitals & Clinics
3.3.2: Diagnostic & Imaging Centers
3.3.3: Home Care Settings
3.3.4: Others
3.4: Global Womens Health Diagnostic Market by Application
3.4.1: osteoporosis testing
3.4.2: OVC testing
3.4.3: cervical cancer testing
3.4.4: breast cancer testing
3.4.5: pregnancy & fertility testing
3.4.6: prenatal genetic screening & carrier testing
3.4.7: infectious disease testing
3.4.8: STD testing
3.4.9: ultrasound tests
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Womens Health Diagnostic Market by Region
4.2: North American Womens Health Diagnostic Market
4.2.2: North American Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
4.3: European Womens Health Diagnostic Market
4.3.1: European Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
4.3.2: European Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
4.4: APAC Womens Health Diagnostic Market
4.4.1: APAC Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
4.4.2: APAC Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
4.5: ROW Womens Health Diagnostic Market
4.5.1: ROW Womens Health Diagnostic Market by End Use Industry Industry: Hospitals & Clinics, Diagnostic & Imaging Centers, Home Care Settings, and Others
4.5.2: ROW Womens Health Diagnostic Market by Application: osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, ultrasound tests, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Womens Health Diagnostic Market by End Use Industry Industry
6.1.2: Growth Opportunities for the Global Womens Health Diagnostic Market by Application
6.1.3: Growth Opportunities for the Global Womens Health Diagnostic Market by Region
6.2: Emerging Trends in the Global Womens Health Diagnostic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Womens Health Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Womens Health Diagnostic Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: F. Hoffmann-la Roche
7.2: Siemens Aktiengesellschaft
7.3: Quest Diagnostics Incorporated
7.4: Ge Healthcare
7.5: Koninklijke Philips
7.6: General Motors
7.7: Abbott Laboratories
7.8: Becton
7.9: Dickinson
7.10: Hologic
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Womens Health Diagnostic Market Report.